Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gravid Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Topical Products
1.2.3 Lasers
1.2.4 Microdermabrasion
1.2.5 Others
1.3 Market by Application
1.3.1 Global Gravid Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Specialty Dermatology Centers
1.3.5 Home-use
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gravid Treatment Market Perspective (2018-2033)
2.2 Gravid Treatment Growth Trends by Region
2.2.1 Global Gravid Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Gravid Treatment Historic Market Size by Region (2018-2023)
2.2.3 Gravid Treatment Forecasted Market Size by Region (2024-2033)
2.3 Gravid Treatment Market Dynamics
2.3.1 Gravid Treatment Industry Trends
2.3.2 Gravid Treatment Market Drivers
2.3.3 Gravid Treatment Market Challenges
2.3.4 Gravid Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gravid Treatment Players by Revenue
3.1.1 Global Top Gravid Treatment Players by Revenue (2018-2023)
3.1.2 Global Gravid Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Gravid Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gravid Treatment Revenue
3.4 Global Gravid Treatment Market Concentration Ratio
3.4.1 Global Gravid Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gravid Treatment Revenue in 2022
3.5 Gravid Treatment Key Players Head office and Area Served
3.6 Key Players Gravid Treatment Product Solution and Service
3.7 Date of Enter into Gravid Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gravid Treatment Breakdown Data by Type
4.1 Global Gravid Treatment Historic Market Size by Type (2018-2023)
4.2 Global Gravid Treatment Forecasted Market Size by Type (2024-2033)
5 Gravid Treatment Breakdown Data by Application
5.1 Global Gravid Treatment Historic Market Size by Application (2018-2023)
5.2 Global Gravid Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Gravid Treatment Market Size (2018-2033)
6.2 North America Gravid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Gravid Treatment Market Size by Country (2018-2023)
6.4 North America Gravid Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gravid Treatment Market Size (2018-2033)
7.2 Europe Gravid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Gravid Treatment Market Size by Country (2018-2023)
7.4 Europe Gravid Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gravid Treatment Market Size (2018-2033)
8.2 Asia-Pacific Gravid Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Gravid Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Gravid Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gravid Treatment Market Size (2018-2033)
9.2 Latin America Gravid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Gravid Treatment Market Size by Country (2018-2023)
9.4 Latin America Gravid Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gravid Treatment Market Size (2018-2033)
10.2 Middle East & Africa Gravid Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Gravid Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Gravid Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Laboratoires Expanscience
11.1.1 Laboratoires Expanscience Company Detail
11.1.2 Laboratoires Expanscience Business Overview
11.1.3 Laboratoires Expanscience Gravid Treatment Introduction
11.1.4 Laboratoires Expanscience Revenue in Gravid Treatment Business (2018-2023)
11.1.5 Laboratoires Expanscience Recent Development
11.2 Clarins Group
11.2.1 Clarins Group Company Detail
11.2.2 Clarins Group Business Overview
11.2.3 Clarins Group Gravid Treatment Introduction
11.2.4 Clarins Group Revenue in Gravid Treatment Business (2018-2023)
11.2.5 Clarins Group Recent Development
11.3 Merz North America, Inc. (Merz Group)
11.3.1 Merz North America, Inc. (Merz Group) Company Detail
11.3.2 Merz North America, Inc. (Merz Group) Business Overview
11.3.3 Merz North America, Inc. (Merz Group) Gravid Treatment Introduction
11.3.4 Merz North America, Inc. (Merz Group) Revenue in Gravid Treatment Business (2018-2023)
11.3.5 Merz North America, Inc. (Merz Group) Recent Development
11.4 E.T. Browne Drug
11.4.1 E.T. Browne Drug Company Detail
11.4.2 E.T. Browne Drug Business Overview
11.4.3 E.T. Browne Drug Gravid Treatment Introduction
11.4.4 E.T. Browne Drug Revenue in Gravid Treatment Business (2018-2023)
11.4.5 E.T. Browne Drug Recent Development
11.5 Cynosure
11.5.1 Cynosure Company Detail
11.5.2 Cynosure Business Overview
11.5.3 Cynosure Gravid Treatment Introduction
11.5.4 Cynosure Revenue in Gravid Treatment Business (2018-2023)
11.5.5 Cynosure Recent Development
11.6 Syneron Medical Ltd.
11.6.1 Syneron Medical Ltd. Company Detail
11.6.2 Syneron Medical Ltd. Business Overview
11.6.3 Syneron Medical Ltd. Gravid Treatment Introduction
11.6.4 Syneron Medical Ltd. Revenue in Gravid Treatment Business (2018-2023)
11.6.5 Syneron Medical Ltd. Recent Development
11.7 Union-Swiss (Pty) Ltd.
11.7.1 Union-Swiss (Pty) Ltd. Company Detail
11.7.2 Union-Swiss (Pty) Ltd. Business Overview
11.7.3 Union-Swiss (Pty) Ltd. Gravid Treatment Introduction
11.7.4 Union-Swiss (Pty) Ltd. Revenue in Gravid Treatment Business (2018-2023)
11.7.5 Union-Swiss (Pty) Ltd. Recent Development
11.8 Basq Skincare
11.8.1 Basq Skincare Company Detail
11.8.2 Basq Skincare Business Overview
11.8.3 Basq Skincare Gravid Treatment Introduction
11.8.4 Basq Skincare Revenue in Gravid Treatment Business (2018-2023)
11.8.5 Basq Skincare Recent Development
11.9 Ellipse A/S
11.9.1 Ellipse A/S Company Detail
11.9.2 Ellipse A/S Business Overview
11.9.3 Ellipse A/S Gravid Treatment Introduction
11.9.4 Ellipse A/S Revenue in Gravid Treatment Business (2018-2023)
11.9.5 Ellipse A/S Recent Development
11.10 The Boppy Company
11.10.1 The Boppy Company Company Detail
11.10.2 The Boppy Company Business Overview
11.10.3 The Boppy Company Gravid Treatment Introduction
11.10.4 The Boppy Company Revenue in Gravid Treatment Business (2018-2023)
11.10.5 The Boppy Company Recent Development
11.11 Helix BioMedix
11.11.1 Helix BioMedix Company Detail
11.11.2 Helix BioMedix Business Overview
11.11.3 Helix BioMedix Gravid Treatment Introduction
11.11.4 Helix BioMedix Revenue in Gravid Treatment Business (2018-2023)
11.11.5 Helix BioMedix Recent Development
11.12 Weleda AG
11.12.1 Weleda AG Company Detail
11.12.2 Weleda AG Business Overview
11.12.3 Weleda AG Gravid Treatment Introduction
11.12.4 Weleda AG Revenue in Gravid Treatment Business (2018-2023)
11.12.5 Weleda AG Recent Development
11.13 Dermaclara
11.13.1 Dermaclara Company Detail
11.13.2 Dermaclara Business Overview
11.13.3 Dermaclara Gravid Treatment Introduction
11.13.4 Dermaclara Revenue in Gravid Treatment Business (2018-2023)
11.13.5 Dermaclara Recent Development
11.14 Mama Mio US
11.14.1 Mama Mio US Company Detail
11.14.2 Mama Mio US Business Overview
11.14.3 Mama Mio US Gravid Treatment Introduction
11.14.4 Mama Mio US Revenue in Gravid Treatment Business (2018-2023)
11.14.5 Mama Mio US Recent Development
11.15 Centre Light Solutions
11.15.1 Centre Light Solutions Company Detail
11.15.2 Centre Light Solutions Business Overview
11.15.3 Centre Light Solutions Gravid Treatment Introduction
11.15.4 Centre Light Solutions Revenue in Gravid Treatment Business (2018-2023)
11.15.5 Centre Light Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Gravid Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Topical Products
Table 3. Key Players of Lasers
Table 4. Key Players of Microdermabrasion
Table 5. Key Players of Others
Table 6. Global Gravid Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Gravid Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Gravid Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Gravid Treatment Market Share by Region (2018-2023)
Table 10. Global Gravid Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Gravid Treatment Market Share by Region (2024-2033)
Table 12. Gravid Treatment Market Trends
Table 13. Gravid Treatment Market Drivers
Table 14. Gravid Treatment Market Challenges
Table 15. Gravid Treatment Market Restraints
Table 16. Global Gravid Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Gravid Treatment Market Share by Players (2018-2023)
Table 18. Global Top Gravid Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gravid Treatment as of 2022)
Table 19. Ranking of Global Top Gravid Treatment Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Gravid Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gravid Treatment Product Solution and Service
Table 23. Date of Enter into Gravid Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gravid Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Gravid Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Gravid Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Gravid Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Gravid Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Gravid Treatment Revenue Market Share by Application (2018-2023)
Table 31. Global Gravid Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Gravid Treatment Revenue Market Share by Application (2024-2033)
Table 33. North America Gravid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Gravid Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Gravid Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Gravid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Gravid Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Gravid Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Gravid Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Gravid Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Gravid Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Gravid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Gravid Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gravid Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Gravid Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Gravid Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Gravid Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 48. Laboratoires Expanscience Company Detail
Table 49. Laboratoires Expanscience Business Overview
Table 50. Laboratoires Expanscience Gravid Treatment Product
Table 51. Laboratoires Expanscience Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 52. Laboratoires Expanscience Recent Development
Table 53. Clarins Group Company Detail
Table 54. Clarins Group Business Overview
Table 55. Clarins Group Gravid Treatment Product
Table 56. Clarins Group Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 57. Clarins Group Recent Development
Table 58. Merz North America, Inc. (Merz Group) Company Detail
Table 59. Merz North America, Inc. (Merz Group) Business Overview
Table 60. Merz North America, Inc. (Merz Group) Gravid Treatment Product
Table 61. Merz North America, Inc. (Merz Group) Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 62. Merz North America, Inc. (Merz Group) Recent Development
Table 63. E.T. Browne Drug Company Detail
Table 64. E.T. Browne Drug Business Overview
Table 65. E.T. Browne Drug Gravid Treatment Product
Table 66. E.T. Browne Drug Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 67. E.T. Browne Drug Recent Development
Table 68. Cynosure Company Detail
Table 69. Cynosure Business Overview
Table 70. Cynosure Gravid Treatment Product
Table 71. Cynosure Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 72. Cynosure Recent Development
Table 73. Syneron Medical Ltd. Company Detail
Table 74. Syneron Medical Ltd. Business Overview
Table 75. Syneron Medical Ltd. Gravid Treatment Product
Table 76. Syneron Medical Ltd. Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 77. Syneron Medical Ltd. Recent Development
Table 78. Union-Swiss (Pty) Ltd. Company Detail
Table 79. Union-Swiss (Pty) Ltd. Business Overview
Table 80. Union-Swiss (Pty) Ltd. Gravid Treatment Product
Table 81. Union-Swiss (Pty) Ltd. Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 82. Union-Swiss (Pty) Ltd. Recent Development
Table 83. Basq Skincare Company Detail
Table 84. Basq Skincare Business Overview
Table 85. Basq Skincare Gravid Treatment Product
Table 86. Basq Skincare Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 87. Basq Skincare Recent Development
Table 88. Ellipse A/S Company Detail
Table 89. Ellipse A/S Business Overview
Table 90. Ellipse A/S Gravid Treatment Product
Table 91. Ellipse A/S Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 92. Ellipse A/S Recent Development
Table 93. The Boppy Company Company Detail
Table 94. The Boppy Company Business Overview
Table 95. The Boppy Company Gravid Treatment Product
Table 96. The Boppy Company Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 97. The Boppy Company Recent Development
Table 98. Helix BioMedix Company Detail
Table 99. Helix BioMedix Business Overview
Table 100. Helix BioMedix Gravid Treatment Product
Table 101. Helix BioMedix Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 102. Helix BioMedix Recent Development
Table 103. Weleda AG Company Detail
Table 104. Weleda AG Business Overview
Table 105. Weleda AG Gravid Treatment Product
Table 106. Weleda AG Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 107. Weleda AG Recent Development
Table 108. Dermaclara Company Detail
Table 109. Dermaclara Business Overview
Table 110. Dermaclara Gravid Treatment Product
Table 111. Dermaclara Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 112. Dermaclara Recent Development
Table 113. Mama Mio US Company Detail
Table 114. Mama Mio US Business Overview
Table 115. Mama Mio US Gravid Treatment Product
Table 116. Mama Mio US Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 117. Mama Mio US Recent Development
Table 118. Centre Light Solutions Company Detail
Table 119. Centre Light Solutions Business Overview
Table 120. Centre Light Solutions Gravid Treatment Product
Table 121. Centre Light Solutions Revenue in Gravid Treatment Business (2018-2023) & (US$ Million)
Table 122. Centre Light Solutions Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gravid Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Gravid Treatment Market Share by Type: 2022 VS 2033
Figure 3. Topical Products Features
Figure 4. Lasers Features
Figure 5. Microdermabrasion Features
Figure 6. Others Features
Figure 7. Global Gravid Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Gravid Treatment Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Specialty Dermatology Centers Case Studies
Figure 12. Home-use Case Studies
Figure 13. Others Case Studies
Figure 14. Gravid Treatment Report Years Considered
Figure 15. Global Gravid Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Gravid Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Gravid Treatment Market Share by Region: 2022 VS 2033
Figure 18. Global Gravid Treatment Market Share by Players in 2022
Figure 19. Global Top Gravid Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gravid Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Gravid Treatment Revenue in 2022
Figure 21. North America Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Gravid Treatment Market Share by Country (2018-2033)
Figure 23. United States Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Gravid Treatment Market Share by Country (2018-2033)
Figure 27. Germany Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Gravid Treatment Market Share by Region (2018-2033)
Figure 35. China Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Gravid Treatment Market Share by Country (2018-2033)
Figure 43. Mexico Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Gravid Treatment Market Share by Country (2018-2033)
Figure 47. Turkey Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Gravid Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Laboratoires Expanscience Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 50. Clarins Group Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 51. Merz North America, Inc. (Merz Group) Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 52. E.T. Browne Drug Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 53. Cynosure Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 54. Syneron Medical Ltd. Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 55. Union-Swiss (Pty) Ltd. Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 56. Basq Skincare Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 57. Ellipse A/S Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 58. The Boppy Company Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 59. Helix BioMedix Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 60. Weleda AG Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 61. Dermaclara Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 62. Mama Mio US Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 63. Centre Light Solutions Revenue Growth Rate in Gravid Treatment Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed